Cases from a busy nuclear cardiology laboratory

  • Jeremy S. WhiteEmail author
  • Ami E. Iskandrian
  • Fadi G. Hage

Case 1

A 46-year-old man with a history of coronary artery disease (CAD) status post drug-eluting stent placement 8 years prior, and heart failure with reduced left ventricular (LV) ejection fraction (EF) presented to the emergency room with shortness of breath, chest pain, and malaise of 1 month duration. Physical examination was normal with a heart rate of 87 beats per minute (bpm) and blood pressure of 129/83 mmHg. The chest x-ray showed no acute abnormality. The electrocardiogram (ECG) is shown below (Figure  1A). Laboratory studies were remarkable for an elevated hemoglobin (17.3gm/dl), normal BNP (41.0 pg/ml), and undetectable Troponin-I (<0.030 ng/ml).



Dr. Hage reports research grant support from Astellas Pharma and GE Healthcare. Jeremy S. White and Ami E. Iskandrian have no conflict of interest.


  1. 1.
    Mannting F, Zabradina Y, Dass C. Significance of increased right ventricular uptake on 99m Tc-sestamibi SPECT in patients with coronary artery disease. J Nucl Med. 1999;40(6):889–94.Google Scholar
  2. 2.
    Farag AA, Heo J, Tauxe L, Bhambhvani P, Germano G, Kavanagh P, et al. Detection and quantitation of right ventricular reversible perfusion defects by stress SPECT myocardial perfusion imaging: A proof-of-principle study. J Nucl Cardiol. 2019;26(1):266–71.CrossRefGoogle Scholar
  3. 3.
    Kaufmann PA, Camici PG. Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications. J Nucl Med. 2005;46(1):75–88.Google Scholar
  4. 4.
    Lauer M, Froelicher ES, Williams M, Kligfield P. Exercise testing in asymptomatic adults: A statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2005;112:771–6.CrossRefGoogle Scholar
  5. 5.
    Bajaj NS, Singh S, Farag A, El-Hajj S, Heo J, Iskandrian AE, et al. The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging. J Nucl Cardiol. 2016;23(3):390–413.CrossRefGoogle Scholar
  6. 6.
    Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992;20(5):1118–26.CrossRefGoogle Scholar
  7. 7.
    Mets OM, Vliegenthart R, Gondrie MJ, Viergever MA, Oudkerk M, de Koning HJ, et al. Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging. 2013;6(8):899–907.CrossRefGoogle Scholar
  8. 8.
    Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63(4):380–406.CrossRefGoogle Scholar
  9. 9.
    Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: A spasm-thrombus interplay. Am Heart J. 1994;128(6 Pt 1):1237–9.CrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2019

Authors and Affiliations

  • Jeremy S. White
    • 1
    • 2
    Email author
  • Ami E. Iskandrian
    • 1
  • Fadi G. Hage
    • 1
    • 2
  1. 1.Division of Cardiovascular Disease, Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Section of CardiologyBirmingham Veterans Affairs Medical CenterBirminghamUSA

Personalised recommendations